View Older Stories

Jun 10, 2026 11:22AM Johnson & Johnson faces $32 million verdict in Los Angeles asbestos case

Jun 3, 2026 03:14AM Johnson & Johnson reports nipocalimab shows stronger response in Sjögren's patients

May 29, 2026 02:00PM J&J's RYBREVANT plus LAZCLUZE shows 3.5-year survival in lung cancer study

May 29, 2026 08:41AM Johnson & Johnson TECVAYLI shows survival benefits in myeloma study

May 26, 2026 08:03AM DePuy Synthes signs exclusive distribution deal with CGBIO for bone graft

May 15, 2026 02:58PM FDA approves accord Biopharma's Immgolis, a biosimilar to Simponi

May 14, 2026 04:01PM Johnson & Johnson survey finds bladder cancer treatments impact patient quality of life

May 13, 2026 06:10AM Leerink Partners Upgrades Johnson & Johnson (JNJ) to Outperform

May 12, 2026 07:45AM Johnson & Johnson launches Shockwave C2 Aero coronary catheter globally

May 11, 2026 08:01AM Johnson & Johnson presents neuropsychiatry data at medical conferences

May 6, 2026 04:28AM Protagonist Therapeutics (PTGX) PT Raised to $137 at Citizens

May 5, 2026 08:05AM Johnson & Johnson's TREMFYA shows efficacy in perianal fistulizing Crohn's

May 5, 2026 08:05AM Johnson & Johnson reports positive phase 2b results for experimental IBD therapy

May 5, 2026 07:00AM Johnson & Johnson reports clinical trial results for robotic surgery system

May 4, 2026 08:03AM Johnson & Johnson presents CAPLYTA analysis for depression treatment

Apr 24, 2026 04:23PM Johnson & Johnson (JNJ) to start marketing 4 meds on TrumpRX - CBS

Apr 24, 2026 08:38AM Johnson & Johnson to acquire medical device firm Atraverse Medical

Apr 22, 2026 08:07AM Johnson & Johnson IMAAVY shows sustained disease control for myasthenia gravis

Apr 21, 2026 07:45AM Johnson & Johnson launches CARTOSOUND SONATA at HRS 2026 medical conference

Apr 20, 2026 03:56PM Johnson & Johnson (JNJ) PT Raised to $230 at Freedom Broker

Apr 20, 2026 06:53AM Johnson & Johnson (JNJ) PT Raised to $266 at Guggenheim

Apr 15, 2026 08:35AM Johnson & Johnson (JNJ) PT Raised to $283 at Morgan Stanley

Apr 15, 2026 07:21AM Johnson & Johnson (JNJ) PT Raised to $250 at Stifel on Beat and Raise Performance

Apr 15, 2026 07:10AM Johnson & Johnson (JNJ) PT Raised to $355 at Argus

Apr 15, 2026 06:53AM Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ), 'continue to see JNJ as one of our Top Picks'

Apr 15, 2026 05:57AM Johnson & Johnson (JNJ) PT Raised to $255 at Barclays

Apr 15, 2026 05:25AM Johnson & Johnson (JNJ) PT Raised to $251 at Bernstein SocGen Group

Apr 14, 2026 05:09PM Johnson & Johnson (JNJ) PT Raised to $265 at RBC Capital

Apr 14, 2026 06:45AM Johnson & Johnson beats estimates, raises 2026 guidance

Apr 14, 2026 06:23AM Johnson & Johnson (JNJ) Raises Quarterly Dividend 3.1% to $1.34; 2.3% Yield

Apr 14, 2026 06:22AM Johnson & Johnson (JNJ) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY Guidance

Apr 14, 2026 02:00AM Johnson & Johnson Q1 earnings preview: analysts eye pharma strength, legal overhang

Apr 13, 2026 11:08AM Johnson & Johnson (JNJ) call put ratio 1.5 calls to 1 put into quarter results

Apr 13, 2026 05:05AM Johnson & Johnson (JNJ) call put ratio 1 call to 1.1 puts into quarter results

Apr 10, 2026 08:01AM Johnson & Johnson presents clinical data for TECNIS PureSee lens at ASCRS

Apr 8, 2026 04:43AM TD Cowen Assumes Johnson & Johnson (JNJ) at Buy

Apr 7, 2026 08:05AM Johnson & Johnson launches VARIPULSE Pro in Europe with CE Mark approval

Apr 1, 2026 12:52PM Johnson & Johnson receives permanent billing code for bladder cancer treatment

Mar 30, 2026 07:16AM Royalty Pharma partners with J&J on $500M drug development deal

Mar 30, 2026 04:21AM J&J reports one-year ICOTYDE psoriasis treatment data shows sustained results

Mar 25, 2026 07:26AM Nanobiotix stock jumps on takeover report involving J&J

Mar 23, 2026 07:45AM TuHURA names former J&J oncology executive as chief medical officer

Mar 19, 2026 06:33AM Guggenheim Reiterates Buy Rating on Johnson & Johnson (JNJ)

Mar 18, 2026 11:26AM BofA Securities remains Neutral on Johnson & Johnson (JNJ): early Ico approval was 'modest upside'

Mar 18, 2026 11:23AM Morgan Stanley stays Overweight on Johnson & Johnson (JNJ) following 'expected positive' Ico approval

Mar 18, 2026 08:43AM Wolfe Research stays Outperform on Johnson & Johnson (JNJ): focus shifts to upcoming h2h trial data

Mar 17, 2026 03:03PM Johnson & Johnson wins new trial on punitive damages in baby powder case

Mar 13, 2026 12:36PM J&J reports 89% response rate in bladder cancer drug trial

Mar 5, 2026 11:30PM This pharma giant is positioned for earnings beats as new drug cycle gains pace

Mar 2, 2026 04:53PM Johnson & Johnson (JNJ) PT Raised to $253 at BofA Securities

View Older Stories